Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2003
07/23/2003EP1328647A1 Isomaltulose synthase
07/23/2003EP1328646A2 Regulation of human adenylate cyclase, type iv
07/23/2003EP1328645A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
07/23/2003EP1328641A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
07/23/2003EP1328634A2 Genes expressed in the cell cycle
07/23/2003EP1328631A2 Her-2/neu fusion proteins
07/23/2003EP1328630A2 Secreted proteins
07/23/2003EP1328629A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
07/23/2003EP1328625A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328622A2 Protein c or activated protein c-like molecules
07/23/2003EP1328620A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells
07/23/2003EP1328619A1 Human tuberoinfundibular peptide of 39 residues
07/23/2003EP1328550A2 Methods of selecting compounds for modulation of bladder function
07/23/2003EP1328545A1 Human gene critical to fertility
07/23/2003EP1328537A1 Antisense modulation of bh3 interacting domain death agonist expression
07/23/2003EP1328295A2 New interferon beta-like molecules
07/23/2003EP1328293A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
07/23/2003EP1328291A2 Viruses targeted to hypoxic cells and tissues
07/23/2003EP1328287A1 Compositions and methods for wt1 specific immunotherapy
07/23/2003EP1328151A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
07/23/2003EP1029040B1 Method of increasing efficiency of directed evolution of a gene using phagemid
07/23/2003EP1007682A4 Novel nucleic acid molecules and uses therefor
07/23/2003EP0888540B1 Method of identifying mhc-class i restricted antigens endogenously processed by a cellular secretory pathway
07/23/2003EP0814827B1 Vascular endothelial growth factor-b
07/23/2003EP0602113B1 Callus-specific promoters
07/23/2003EP0586607B1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2
07/23/2003CN1432067A Sperm-DNA complexes for genetically modifying non-human animals
07/23/2003CN1432065A Bacterial insecticidal proteins
07/23/2003CN1432063A Humanised antibodies to epidermal growth factor receptor
07/23/2003CN1432058A Redeposition or backstain inhibition during stonewashing process
07/23/2003CN1431300A Method for producing transgene paddy with amount of spikelet being increased
07/23/2003CN1431299A Serum-free medium of human epidermis cell and its cultivating method and application
07/23/2003CN1431298A Antineoplastic immunocompetent cell-cell of DCIC, its preparing method and applications
07/23/2003CN1431297A Serum-free medium and concentrated solution as well as its preparing method
07/23/2003CN1115414C Virus carrier used for gene therapy
07/23/2003CN1115412C Pro-Urokinase mutants
07/22/2003US6596930 Modification of cereal grain hardness via expression of puroindoline protein
07/22/2003US6596929 Regulatory sequences for use in generation of disease and damage resistant plants
07/22/2003US6596928 Plants synthesizing a modified starch, the generation of the plants, their use, and the modified starch
07/22/2003US6596927 Genes coding for flavone synthases
07/22/2003US6596925 Compositions and methods for the modification of gene expression
07/22/2003US6596923 Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases
07/22/2003US6596847 Tissue factor protein variants
07/22/2003US6596698 Localized arterial transduction of RB2/pl30 via a viral vector at the time of angioplasty drastically reduces neointimal hyperplasia and prevents restenosis
07/22/2003US6596694 Caloporoside derivatives, methods of their preparation and use
07/22/2003US6596541 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin
07/22/2003US6596540 Method for introduction of an exogenous genetic substance or a physiologically active compound
07/22/2003US6596538 Expression vector coding enzymatic polypeptide for use in the preparation of cosmetics, detergents, plastics and lubricants
07/22/2003US6596536 Monoclonal antibody for use in the treatment and diagnosis of autoimmune and arthritic diseases
07/22/2003US6596535 Adeno-associated viral vector for use as tool in the transfer of genetic information for use in the treatment of arthritis
07/22/2003US6596533 Polypeptide for use in the treatment of infections and cell proliferative disorders
07/22/2003US6596531 Two stage method for thawing cryopreserved cells
07/22/2003US6596527 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of liver disorders
07/22/2003US6596526 Furin polypeptides with improved characteristics
07/22/2003US6596525 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
07/22/2003US6596514 Nucleotide sequences which can improve expression of recombinant proteins two- to eight-fold in stable cell pools when present in an expression vector
07/22/2003US6596508 Plasmid for use in te expressing of heterologous proteins
07/22/2003US6596485 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries
07/22/2003US6596482 Nucleic acids encoding BAZ1α transcriptional regulator and methods of use
07/22/2003US6596473 Detection of antiapotosis protein; obtain genetically engineered cells, measure viable cells, incubate with antiapoptosis agent, compare with control, evaluate adjustment in apoptosis activity
07/22/2003US6596472 Reproductive cultures containing colloidal silver
07/22/2003US6596471 Method of cross-linking tissue with a bis-maleimide compound
07/22/2003US6596275 Increasing release of PGE-2, IL-10 and/or IL-4; decreasing expression and secretion of IL-1, IL-12 and/or IFM gamma cytokines; decreasing prescence of CD80, CD86 and/or CD40 antigens; having polylysine-cDNA encoding cell nucleus
07/22/2003US6596274 Dermal substitute in cutaneous lesions; repairing damaged connective tissue
07/22/2003US6596180 System and method for the production of autologous platelet gel
07/22/2003US6596179 Apparatus for the separation of biologic components from heterogeneous cell populations
07/22/2003CA2329473C Dna encoding prostaglandin receptor ep1
07/18/2003CA2369985A1 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
07/17/2003WO2003058248A2 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
07/17/2003WO2003058197A2 Detection of molecular interactions by beta-lactamase reporter fragment complementation
07/17/2003WO2003058192A2 System and method for differentiating between cells with normal and pathologically altered cytoskeleton
07/17/2003WO2003057926A1 Gene products differentially expressed in cancerous breast cells and their methods of use
07/17/2003WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
07/17/2003WO2003057907A1 Expression and purification of atm protein using vaccinia virus
07/17/2003WO2003057906A1 A new vector for genetically modifying non-human animals
07/17/2003WO2003057898A2 Methods and materials for modulating p2x2
07/17/2003WO2003057879A1 Novel udp-n-acetyl-d-galactosamine:polypeptide n-acetylgalactosamine transferase and nucleic acid encoding the same
07/17/2003WO2003057878A1 INDUCTION OF THE FORMATION OF INSULIN-PRODUCING CELLS VIA GENE TRANSFER OF PANCREATIC β-CELL-ASSOCIATED TRANSCRIPTIONAL FACTOR
07/17/2003WO2003057868A1 Novel n-acetylglucosamines transferase and nucleic acids encoding the same
07/17/2003WO2003057866A1 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same
07/17/2003WO2003057865A1 Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements
07/17/2003WO2003057864A1 Transgenic papp-a non-human mammals
07/17/2003WO2003057862A2 Transdifferentiation of pancreatic acinar cells
07/17/2003WO2003057859A2 Genes for altering mitochondrial function and for hybrid seed production
07/17/2003WO2003057856A2 Dominant negative proteins and methods thereof
07/17/2003WO2003057854A2 Novel proteins and nucleic acids encoding same
07/17/2003WO2003057853A2 Oxidative stress-resistant cell lines and methods of use thereof
07/17/2003WO2003057836A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
07/17/2003WO2003057835A2 Pak5-related compositions and methods
07/17/2003WO2003057833A2 Mutant chromophores/fluorophores and methods for making and using the same
07/17/2003WO2003057830A2 Compositions and methods for hydroxylating epothilones
07/17/2003WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains
07/17/2003WO2003057826A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE
07/17/2003WO2003057823A2 Epitope synchronization in antigen presenting cells
07/17/2003WO2003057820A2 Peptide activators of vegf
07/17/2003WO2003057729A2 Mammal prolactin variants
07/17/2003WO2003057726A1 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants
07/17/2003WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
07/17/2003WO2003057719A2 Methods of modulating localization and physiological function of ip3 receptors